Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely (Q43707492)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely
scientific article

    Statements

    Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely (English)
    Stéphane Chevaliez
    Christophe Hézode
    Stéphane Bahrami
    Marion Grare
    3 December 2012
    676-683

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit